Effects of different mind–body exercises on quality of life and cancer-related fatigue in breast cancer survivors: a systematic review and network meta-analysis
A partir d'une revue systématique de la littérature publiée jusqu'en octobre 2023 (121 études, 11 072 patientes), cette méta-analyse évalue l'efficacité des pratiques corps-esprit (relaxation, yoga, Tai Chi, etc.) pour soulager la fatigue liée au cancer et améliorer la qualité de vie des patientes ayant survécu à un cancer
Purpose: To compare the efficacy of the different mind–body exercises (MBEs) for quality of life (QOL) and cancer-related fatigue (CRF) in women breast cancer (BC) survivors.
Methods: This review searched published randomized controlled trials (RCTs) in eight electronic databases: PubMed, Web of Science, Embase, Cochrane CENTRAL, EBSCO, CNKI, VIP, and WanFang from inception to October 30, 2023. NMA and comparative effects ranking were performed using STATA 17.0 software.
Results: This study included 121 studies with 11,072 women BC patients and eight different MBEs. Baduanjin showed the largest effect size in significantly improving subjective QOL (SMD = 3.03, 95% CI (2.04, 4.01)) compared with the control group, followed by relaxation training (SMD = 1.44, 95% CI (1.04, 1.85)), yoga (SMD = 0.89, 95% CI (0.36, 1.42)), mindfulness (SMD = 0.83, 95% CI (0.54, 1.12)), and Tai chi (SMD = 0.76, 95% CI (0.04, 1.48)). Furthermore, Tai chi (SMD = − 1.42, 95% CI (− 2.21, − 0.63)) ranked first in significantly reducing CRF in BC patients compared with the control group, followed by mindfulness (SMD = − 0.81, 95% CI (− 1.11, − 0.50)), relaxation training (SMD = − 0.70, 95% CI (− 1.12, − 0.28)), and yoga (SMD = − 0.53, 95% CI (− 0.88, − 0.18)).
Conclusions: Baduanjin and Tai chi are the most effective MBEs for improving QOL and CRF in female BC survivors, respectively. We recommend that healthcare providers prioritize Baduanjin and Tai chi as complementary therapies for BC survivors.
Implications for Cancer Survivors: Baduanjin and Tai chi have significant effects on improving the QOL of breast cancer patients and alleviating CRF, which is worthy of promotion and application.
Journal of Cancer Survivorship , résumé, 2025